|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,010.00 DKK | -2.24% |
|
-1.18% | +34.67% |
| 10/12 | BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours | MT |
| 09/12 | Genmab shares encouraging early-stage data on epcoritamab for RT patients | RE |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 17.57x | 3.34x | -4.92x | 4.34x | 11.54x | 12.26x | -.--% | 1.97TCr | ||
| 50.93x | 8.28x | 2.02x | 12.4x | 44.72x | 46x | -.--% | 5.57TCr | ||
| -31.88x | 63.71x | -2.99x | 80.89x | -35.76x | -35.22x | -.--% | 4.19TCr | ||
| 16.2x | 3.82x | 0.22x | 5.68x | 12.87x | 14.88x | 1.75% | 3.86TCr | ||
| -25.86x | 1.12x | -1.53x | 3.49x | -10.23x | -7.79x | -.--% | 2.34TCr | ||
| 27.79x | 2.57x | 0.73x | 5.44x | 15.09x | 18.79x | -.--% | 1.74TCr | ||
| -514.7x | 14.1x | 8.12x | 29.79x | 702.43x | -599.11x | -.--% | 1.47TCr | ||
| -14.46x | - | -0.05x | 181.97x | -28.37x | -14.13x | -.--% | 1.44TCr | ||
| -190.92x | 23.07x | -2.34x | 47.06x | -187.75x | -162.6x | -.--% | 1.34TCr | ||
| -57.95x | 21.39x | 1.05x | 13.02x | -55.19x | -49.76x | -.--% | 1.29TCr | ||
| 16.55x | 4.34x | 0.37x | 4.61x | 11.45x | 12.87x | -.--% | 1.14TCr | ||
| -20.77x | 17.24x | -0x | 20.95x | -32.47x | -20.38x | -.--% | 931.65Cr | ||
| -18.84x | 8.94x | -0.41x | - | -19.41x | -18.75x | -.--% | 837.69Cr | ||
| -10.15x | -15.49x | -0.5x | 88.6x | -12.43x | -12.17x | -.--% | 784.08Cr | ||
| -16.44x | 12.84x | -0.22x | 125.54x | -19.1x | -18.6x | -.--% | 730.16Cr | ||
| 790.41x | 41.67x | -6.56x | 95.24x | 856.76x | 1108.29x | - | 701.43Cr | ||
| Average | 1.09x | 14.06x | -0.44x | 47.93x | 78.38x | 17.16x | 0.12% | 1.9TCr | |
| Weighted average by Cap. | -11.72x | 16.47x | -0.24x | 37.09x | 45.81x | -8.09x | 0.23% |
- Stock Market
- Equities
- GMAB Stock
- Sector Genmab A/S
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















